1,2,3,4-Tetrahydro-2,6-naphthyridine Dihydrochloride - CAS 449175-43-3
Catalog: |
BB057528 |
Product Name: |
1,2,3,4-Tetrahydro-2,6-naphthyridine Dihydrochloride |
CAS: |
449175-43-3 |
Synonyms: |
1,2,3,4-Tetrahydro-2,6-naphthyridine dihydrochloride; 1,2,3,4-Tetrahydro-[2,6]naphthyridine dihydrochloride; 1,2,3,4-tetrahydro-2,6-naphthyridine; dihydrochloride |
IUPAC Name: | 1,2,3,4-tetrahydro-2,6-naphthyridinedihydrochloride |
Description: | 1,2,3,4-Tetrahydro-2,6-naphthyridine Dihydrochloride is a salt analog of 1,2,3,4-Tetrahydro-2,6-naphthyridine (CAT# T295698), which is used in the synthetic preparation of quinolizidinone carboxylic acid selective M1 allosteric modulators. It may be useful in the preparation of isoquinolinylphenyloxazolidinone antibacterials and in the preparation of cyclohexanedicarboxamides as cathepsin inhibitors. |
Molecular Weight: | 134.18 + 2(36.46) |
Molecular Formula: | C8H10N2·2(HCl) |
Canonical SMILES: | C1CNCC2=C1C=NC=C2.Cl.Cl |
InChI: | InChI=1S/C8H10N2.2ClH/c1-3-9-6-8-2-4-10-5-7(1)8/h1,3,6,10H,2,4-5H22*1H |
InChI Key: | HXPFQYFUMUHIAT-UHFFFAOYSA-N |
References: | Kuduk, S. D., et al. Bioorganic Med. Chem. Lett., 21, 1710 (2011); Paget, S. D., et al. PCT Int. Appl., 49 pp. (2002); Dossetter, A. G., et al. PCT Int. Appl., 66 pp. (2008). |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
AU-2011304666-A1 | Substituted benzamide compounds | 20100922 |
CA-2811796-A1 | Substituted benzamide compounds | 20100922 |
EP-2619178-A1 | Substituted benzamide compounds | 20100922 |
JP-2013540750-A | Substituted benzamide compounds | 20100922 |
KR-20140000682-A | Substituted Benzamide Compounds | 20100922 |
US-2012071461-A1 | Substituted Benzamide Compounds | 20100922 |
US-8680159-B2 | Bradykinin 1 receptor modulating compounds | 20100922 |
WO-2012038081-A1 | Substituted benzamide compounds | 20100922 |
WO-2009001128-A1 | 1,2-cycl0hexane dicarboxamides as cathepsin inhibitors | 20070626 |
Complexity: | 114 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 3 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 206.0377538 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 3 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 206.0377538 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 24.9Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS